EBIXA 10mg Price

Overview

Welcome to Dwaey, specifically on EBIXA 10mg Tablets page.
This medicine contains an important and useful components, as it consists of Memantine HCl.
EBIXA 10mg is available in the market in concentration 10mg/Tablet and in the form of Tablets.

H. LUNDBECK A/S is the producer of EBIXA 10mg and it is imported from DENMARK, The most popular alternatives of EBIXA 10mg are listed downward .

Mode Of Action

Memantine, a derivative of amantadine, is a noncompetitive N-methyl-D-aspartate (NMDA)-receptor antagonist. It affects transmission of glutamate, the primary excitatory neurotransmitter in the CNS. Glutamate may contribute to the pathogenesis of Alzheimer's disease by overstimulating various glutamate receptors resulting in excitotoxicity and neuronal cell death.

Indication

• Alzheimer's dementia.

Precaution

Renal impairment; epilepsy. Pregnancy and lactation. Closely monitor patients with recent MI, uncompensated CHF, uncontrolled hypertension. Predisposition to convulsions; conditions that increase urinary pH. Lactation: Unknown whether drug is excreted into breast milk; use with caution

Side Effects

• 1-10% Dizziness (7%)
• Confusion (6%)
• Headache (6%)
• Constipation (5%)
• Cough (4%)
• Hypertension (4%)
• Backache (3%)
• Pain (3%)
• Somnolence (3%)
• Syncope (3%)
• Vomiting (3%)
• Dyspnea (2%)
• Fatigue (2%) <1% Acute renal failure
• Cerebral infarction
• Cerebrovascular accident
• Deep venous thrombosis
• Hepatitis
• liver failure
• Intracranial hemorrhage
• Neuroleptic malignant syndrome
• Seizure (including grand mal)
• Stevens-Johnson syndrome
• Transient ischemic attack

Contra indication

Hypersensitivity to memantine or components of the formulation. Severe renal impairment.

Pregnancy and lactation

Pregnancy category: B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.